PCSK9 and bacterial infectious disease: Besides addressing the impact of adipokines on hepatic PCSK9 levels in various disease settings, researchers have also examined if hepatic PCSK9 expression is modulated by inflammatory mediators, such as exposure to lipopolysaccharide (LPS) after bacterial infection.